chr9-137108482-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 3P and 3B. PM2PP3BP4_ModerateBS1_Supporting
The NM_016219.5(MAN1B1):c.1991C>T(p.Thr664Met) variant causes a missense change. The variant allele was found at a frequency of 0.000129 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016219.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAN1B1 | NM_016219.5 | c.1991C>T | p.Thr664Met | missense_variant | Exon 13 of 13 | ENST00000371589.9 | NP_057303.2 | |
MAN1B1 | NR_045720.2 | n.1981C>T | non_coding_transcript_exon_variant | Exon 13 of 13 | ||||
MAN1B1 | NR_045721.2 | n.2137C>T | non_coding_transcript_exon_variant | Exon 14 of 14 | ||||
MAN1B1 | XM_006716945.5 | c.*520C>T | downstream_gene_variant | XP_006717008.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251474Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135914
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461568Hom.: 0 Cov.: 32 AF XY: 0.000105 AC XY: 76AN XY: 727102
GnomAD4 genome AF: 0.000315 AC: 48AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74472
ClinVar
Submissions by phenotype
Rafiq syndrome Uncertain:3
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 664 of the MAN1B1 protein (p.Thr664Met). This variant is present in population databases (rs200428790, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with MAN1B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 435811). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This sequence variant is a single nucleotide substitution (C>T) at position 1991 of the coding sequence of the MAN1B1 gene that results in a threonine to methionine amino acid change at residue 664 of the mannosidase alpha class 1B member 1 protein. This is a previously reported variant (ClinVar 435811) that has not been observed in individuals affected by MAN1B1-related disorder in the published literature, to our knowledge. This variant is present in 208 of 1613878 alleles (0.013%) in the gnomAD v4.1.0 population dataset. Multiple bioinformatic tools predict that this amino acid change would be damaging, and the Thr664 residue at this position is highly conserved across the vertebrate species examined. Studies examining the functional consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PP3 -
- -
not provided Uncertain:2
Identified by whole exome sequencing in the heterozygous state in an individual with intellectual disability who was also homozygous for a likely pathogenic PEX16 variant (PMID: 26870756); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26870756) -
- -
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.T664M variant (also known as c.1991C>T), located in coding exon 13 of the MAN1B1 gene, results from a C to T substitution at nucleotide position 1991. The threonine at codon 664 is replaced by methionine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at